| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/01/2013 | CN103074302A Anti-C-peptide monoclonal antibody and use thereof in detection of C-peptide content |
| 05/01/2013 | CN103074291A Recombinant porcine epidemic diarrhea virus (PEDV) lactococcus lactis and its construction method and use |
| 05/01/2013 | CN103073644A Specific anti-mouse TIGIT monoclonal antibody and preparation method, identification and application thereof |
| 05/01/2013 | CN103073643A Fertilin Beta extracellular domain high-titer antibody prepared by GST expression system and application thereof |
| 05/01/2013 | CN103073642A CRP monoclonal antibody nanometer latex microsphere composition and preparation process thereof |
| 05/01/2013 | CN103073641A Anti-human Dlk-1 antibody showing anti-tumor activity in vivo |
| 05/01/2013 | CN103073640A Anti-soft-shelled turtle systemic septicemia spherical virus (STSSSV) yolk antibody, preparation method and applications thereof |
| 05/01/2013 | CN103073639A Stabilized polypeptide compositions |
| 05/01/2013 | CN103073634A Specific antibody against herbicide anilofos |
| 05/01/2013 | CN103073633A Antibody against 5-hydroxymethyl furfural |
| 05/01/2013 | CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof |
| 05/01/2013 | CN102321177B Anti-melamine single-chain antibody and application thereof |
| 05/01/2013 | CN101915834B Colloidal gold colloidal gold detection test paper strip of shrimp TSV (Taura Syndrome Virus) |
| 05/01/2013 | CN101768218B Preparation method for PCV-II Cap protein monoclonal antibody, antibody and application |
| 05/01/2013 | CN101706507B Application of anti-human CD45RA monoclonal antibody marked by fluorescein isothiocyanate |
| 05/01/2013 | CN101607995B Monoclonal antibody or binding activity fragment thereof of H5 subtype avian influenza virus hemagglutinin protein and application thereof |
| 05/01/2013 | CN101508733B Human avian influenza specific immunity globulin and preparation thereof |
| 05/01/2013 | CN101258164B A method for the mass production of immunoglobulin fc region deleted initial methionine residues |
| 04/30/2013 | US8431769 Non-aggregating fluorescent proteins and methods for using the same |
| 04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
| 04/30/2013 | US8431687 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 04/30/2013 | US8431686 Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5 |
| 04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
| 04/30/2013 | US8431525 Coelenteramide analogs |
| 04/30/2013 | US8431416 Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates |
| 04/30/2013 | US8431394 Antibody or fragment thereof recognizing Avitag™ and uses thereof |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431365 β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 04/30/2013 | US8431355 Process for screening glycoform-specific antibodies |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431350 Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide |
| 04/30/2013 | US8431349 Compositions and methods for early pregnancy diagnosis |
| 04/30/2013 | US8431134 Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 04/30/2013 | US8431132 Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 04/30/2013 | US8431131 CD38 and obesity |
| 04/30/2013 | US8431130 IL-18 binding proteins |
| 04/30/2013 | US8431129 Method of treating fibroproliferative disorders of the heart and lung |
| 04/30/2013 | US8431128 Enterococcus antigens |
| 04/30/2013 | US8431127 Method for treating pruritus comprising administering an NR10 antagonist |
| 04/30/2013 | US8431126 Antibodies that bind polypeptides involved in the process of bone remodeling |
| 04/30/2013 | US8431125 Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
| 04/30/2013 | CA2531023C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 04/30/2013 | CA2525120C A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 04/30/2013 | CA2503125C Novel composition and methods for the treatment of immune related diseases |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/30/2013 | CA2224256C Method for treating established spontaneous auto-immune diseases in mammals |
| 04/25/2013 | WO2013059593A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | WO2013059531A1 Anti-gcgr antibodies and uses thereof |
| 04/25/2013 | WO2013059426A1 Human endogenous retrovirus peptides, antibodies to the peptides, and methods of use thereof |
| 04/25/2013 | WO2013059323A1 Peg conjugates of exenatide |
| 04/25/2013 | WO2013059299A1 Antibodies for interferon subtypes and interferon/interferon receptor ternary complex and uses thereof |
| 04/25/2013 | WO2013059230A1 Restricted immunoglobulin heavy chain mice |
| 04/25/2013 | WO2013059206A2 Monospecific and bispecific human monoclonal antibodies targeting insulin-growth factor ii (igf-ii) |
| 04/25/2013 | WO2013059168A2 Espirito santo virus and methods for detecting and preventing infection with the same |
| 04/25/2013 | WO2013058388A1 Anti-gap43 antibody |
| 04/25/2013 | WO2013057599A1 Biomarker |
| 04/25/2013 | WO2013057290A1 A m-dc8+ monocyte depleting agent for the prevention or the treatment of a condition associated with a chronic hyperactivation of the immune system |
| 04/25/2013 | WO2013057241A1 Antagonists of il17c for the treatment of inflammatory disorders |
| 04/25/2013 | WO2013057078A1 Separation method for fucosylated antibodies |
| 04/25/2013 | WO2013056984A1 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates |
| 04/25/2013 | WO2013056851A2 Stable multiple antigen-binding antibody |
| 04/25/2013 | WO2013056377A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
| 04/25/2013 | WO2013056352A1 Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers |
| 04/25/2013 | WO2013033319A3 A cluster of neutralizing antibodies to hepatitis c virus |
| 04/25/2013 | WO2013033008A3 Tandem fc bispecific antibodies |
| 04/25/2013 | WO2013025446A3 Anti-fzd10 monoclonal antibodies and methods for their use |
| 04/25/2013 | WO2012021512A8 Erythrocyte-binding therapeutics |
| 04/25/2013 | WO2012010974A8 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 04/25/2013 | WO2011116954A3 Prophylaxis of colorectal and gastrointestinal cancer |
| 04/25/2013 | US20130104259 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 04/25/2013 | US20130102762 Anti-psgl-1 antibodies |
| 04/25/2013 | US20130102761 Solid phase for mixed-mode chromatographic purification of proteins |
| 04/25/2013 | US20130102760 Immunoglobulin Preparations Having Increased Stability |
| 04/25/2013 | US20130102544 Disease-Associated Proteins |
| 04/25/2013 | US20130102494 Novel antibody for the diagnosis and/or prognosis of cancer |
| 04/25/2013 | US20130102030 Antibody Molecules Which Bind IL-17A and IL-17F |
| 04/25/2013 | US20130101665 Self-assembling half-antibodies |
| 04/25/2013 | US20130101608 Human antibody drug conjugates against tissue factor |
| 04/25/2013 | US20130101607 Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) Single Chain FV Antibody Fragment Conjugates and Methods of Use Thereof |
| 04/25/2013 | US20130101605 Modulators and modulation of the interaction between rgm and neogenin |
| 04/25/2013 | US20130101603 Bmp-alk3 antagonists and uses for promoting bone growth |
| 04/25/2013 | US20130101602 Humanized Antibodies Against Human Interferon-Alpha |
| 04/25/2013 | US20130101601 Antibodies directed against nerve growth factor (ngf) |
| 04/25/2013 | US20130101598 Antagonists of il-6 to prevent or treat thrombosis |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101594 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases |
| 04/25/2013 | US20130101593 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 04/25/2013 | US20130101592 S100a4 antibodies and therapeutic uses thereof |
| 04/25/2013 | US20130101591 Methods and compositions based on shiga toxin type 1 protein |
| 04/25/2013 | US20130101590 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 04/25/2013 | US20130101588 Novel glycosylated peptide target in neoplastic cells |
| 04/25/2013 | US20130101587 Anti-psgl-1 antibodies |
| 04/25/2013 | US20130101586 Stable multiple antigen-binding antibody |
| 04/25/2013 | US20130101581 Antibody constant region variant |
| 04/25/2013 | US20130101549 Light targeting molecules and uses thereof |
| 04/25/2013 | US20130101504 Sparc binding antibodies and uses thereof |